Author:
Samara Myrto T.,Cao Haoyin,Helfer Bartosz,Davis John M.,Leucht Stefan
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference83 articles.
1. A comparative analysis of drug safety withdrawals in the UK and the US (1971–1992): implications for current regulatory thinking and policy;Abraham;Soc. Sci. Med.,2005
2. Adams, C.E., Awad, G., Rathbone, J., Thornley, B., 2007. Chlorpromazine versus placebo for schizophrenia. The Cochrane database of systematic reviews, CD000284.
3. Ahmed, U., Jones, H., Adams, C.E., 2010. Chlorpromazine for psychosis induced aggression or agitation. The Cochrane database of systematic reviews, CD007445.
4. A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients;Amin;Psychopharmacol. Bull.,1977
5. AstraZeneca, 2000. A multicentre, double-blind, randomised trial to compare the effects of SEROQUEL and chlorpromazine in patients with treatment resistant schizophrenia (5077IL/0054 [TRESS]).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献